Alberto Bavelloni Selected Research

Phosphatidylinositol Phosphates

8/2005	Quantitative immunodetection of key elements of polyphosphoinositide signal transduction in osteoblasts from arthritic patients shows a direct correlation with cell proliferation.
9/2003	IL1-beta and TNF-alpha induce changes in the nuclear polyphosphoinositide signalling system in osteoblasts similar to that occurring in patients with rheumatoid arthritis: an immunochemical and immunocytochemical study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Bavelloni Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 05/2014
4	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2017
4	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2013
4	Acute Erythroblastic Leukemia (Erythroleukemia) 06/2014 - 05/2002
3	Rheumatoid Arthritis 02/2008 - 09/2003
2	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 10/2020
2	Carcinogenesis 01/2021 - 12/2017
2	Breast Neoplasms (Breast Cancer) 01/2018 - 12/2013
2	Leukemia 04/2015 - 01/2007
2	Acute Promyelocytic Leukemia 05/2014 - 02/2010
2	Osteoarthritis 02/2008 - 08/2005
1	Rhabdomyosarcoma 04/2022
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2022
1	Inflammation (Inflammations) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Diabetes Mellitus 10/2020
1	Thymoma (Thymic Carcinoma) 01/2019
1	Hypoxia (Hypoxemia) 12/2017
1	Metabolic Diseases (Metabolic Disease) 04/2015
1	Hematologic Diseases (Blood Diseases) 08/2014
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 08/2014
1	Hematologic Neoplasms (Hematological Malignancy) 08/2013
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2013
1	Myotonic Dystrophy (Dystrophia Myotonica) 07/2012
1	Type 2 Diabetes Mellitus (MODY) 01/2012
1	Laminopathies 01/2010
1	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 11/2008

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2010
4	Phosphotransferases (Kinase)IBA 10/2020 - 05/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 04/2015
2	Protein Isoforms (Isoforms)IBA 01/2018 - 02/2008
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2014 - 02/2010
2	Cyclin D3IBA 03/2007 - 11/2006
2	Phospholipase C betaIBA 01/2007 - 05/2002
2	Phosphatidylinositol PhosphatesIBA 08/2005 - 09/2003
1	idelalisibIBA 04/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	MC3343IBA 01/2022
1	MethyltransferasesIBA 01/2022
1	Glycogen Synthase KinasesIBA 11/2021
1	Free RadicalsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	NVP-BKM120IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 12/2017
1	kinamycin FIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Cyclin AIBA 01/2017
1	ChromatinIBA 08/2014
1	eIF-2 Kinase (eIF 2 Kinase)IBA 08/2014
1	GlobinsIBA 06/2014
1	ProhibitinsIBA 05/2014
1	Apoptosis Regulatory ProteinsIBA 08/2013
1	Protein Kinases (Protein Kinase)IBA 07/2012
1	Insulin (Novolin)FDA Link 01/2012
1	Tyrosine (L-Tyrosine)FDA Link 02/2010
1	LaminsIBA 01/2010
1	Lamin Type A (Lamin A)IBA 11/2008
1	Complementary DNA (cDNA)IBA 03/2007
1	RNA Splicing FactorsIBA 11/2006
1	Phospholipase C gammaIBA 08/2005
1	protein kinase C zetaIBA 08/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2003
1	Type C PhospholipasesIBA 05/2002

Therapy/Procedure

2	Therapeutics 01/2018 - 04/2015
1	Drug Therapy (Chemotherapy) 01/2020
1	Adjuvant Chemotherapy 01/2018